High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial-Reference-Cited by-同舟云学术

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

Published:2005-03-11 Issue:9 Volume:26 Page:890-896
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Olsson Anders G.,Schwartz Gregory G.,Szarek Michael,Sasiela William J.,Ezekowitz Michael D.,Ganz Peter,Oliver Michael F.,Waters David,Zeiher Andreas

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/26/9/890/9355078/ehi186.pdf

Reference17 articles.

1. Sharret AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation2001;104:1108–1113.

2. Pedersen T, Olsson A, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation1998;97:1453–1460.

3. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med2001;345:494–502.

4. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med2001;344:1879–1887.

5. Plana J, Jones P. The use of statins in acute coronary syndromes: the mechanisms behind the outcomes. Curr Atheroscler Rep2001; 3:355–364.

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Ikigai and longitudinal changes in serum HDL cholesterol levels: the Circulatory Risk in Communities Study (CIRCS);Lipids in Health and Disease;2024-08-28

2. Special Patient Populations;Clinical Lipidology;2024

3. Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol;European Heart Journal Open;2023-12-29

4. Lipids, Oxidation, and Cardiovascular Disease;Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease;2023-07-16

5. Clinical Characteristics and Outcomes of Chinese Patients with Premature Acute Coronary Syndrome;International Heart Journal;2023-03-31